Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Targeted Liposomes Drug Delivery Companies

Targeted liposomes are lipid-based nanoparticles designed to encapsulate and deliver drugs to specific tissues or cells, enhancing drug efficacy and reducing side effects. Several companies specialize in the development of targeted liposomal drug delivery systems.

Targeted Liposomes Drug Delivery Key Companies


Latest Targeted Liposomes Drug Delivery Companies Update:

Pfizer and Acuitas Therapeutics enter a development and option agreement: This strategic partnership empowers Pfizer with a non-exclusive option to license Acuitas' lipid nanoparticle (LNP) technology for up to 10 targets, signifying Pfizer's commitment to innovative solutions in both vaccine and therapeutic development.

Alnylam Pharmaceuticals strengthens its LNP development capabilities: They acquire Viaceutics, a company specializing in high-throughput screening and formulation development for RNA interference (RNAi) therapeutics, aiming to accelerate discovery and delivery of their RNAi therapies.

Arrowhead Pharmaceuticals announces the first patient dosed in its Phase 1b/2a clinical trial for AROENVI (ARO-C04): This investigational siRNA therapy leverages Arrowhead's proprietary DuoHex2™ delivery platform to target ENPP3 for the treatment of non-alcoholic steatohepatitis (NASH).

Genmab and Roche unveil Mosquirix™ (tezepelumab): This first-in-class biologic, delivered via subcutaneous injection, utilizes a specifically designed monoclonal antibody targeted against IL-5 receptor α to control severe asthma.

List of Targeted Liposomes Drug Delivery Key companies in the market

  • Catalent (US)

  • Pacira Pharmaceuticals, Inc. (US)

  • Baxter (US)

  • Lonza (Switzerland)

  • Evonik (Germany)

  • Merck KGaA (Germany)

  • Fareva (France)

  • Vetter (Germany)

  • Polymun Scientific Immunbiologische Forschung GmbH (Austria)

  • Recipharm AB (Sweden)

  • Dalton Pharma Services (Canada)

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.